Schrodinger (NASDAQ:SDGR) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen upgraded shares of Schrodinger (NASDAQ:SDGR) from a sell rating to a hold rating in a research note issued to investors on Saturday morning.

Several other equities analysts also recently weighed in on SDGR. KeyCorp dropped their price objective on Schrodinger from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Thursday, January 8th. UBS Group initiated coverage on Schrodinger in a research report on Wednesday, January 7th. They issued a “neutral” rating and a $18.00 price target for the company. Bank of America raised Schrodinger from a “neutral” rating to a “buy” rating and set a $24.00 price target for the company in a research note on Monday, December 15th. Weiss Ratings reissued a “sell (e+)” rating on shares of Schrodinger in a research note on Friday, January 9th. Finally, TD Cowen restated a “buy” rating on shares of Schrodinger in a research report on Thursday, January 8th. Five research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $24.33.

Schrodinger Stock Down 2.4%

Shares of SDGR opened at $13.97 on Friday. Schrodinger has a 52-week low of $13.44 and a 52-week high of $28.47. The company has a 50-day simple moving average of $17.50 and a 200-day simple moving average of $19.01. The company has a market capitalization of $1.03 billion, a PE ratio of -5.80 and a beta of 1.54.

Schrodinger (NASDAQ:SDGR) last issued its earnings results on Wednesday, November 5th. The company reported ($0.45) earnings per share for the quarter, topping the consensus estimate of ($0.72) by $0.27. Schrodinger had a negative net margin of 68.49% and a negative return on equity of 48.24%. The company had revenue of $54.32 million for the quarter, compared to analyst estimates of $50.51 million. During the same period in the prior year, the business posted ($0.87) earnings per share. The firm’s revenue for the quarter was up 53.9% compared to the same quarter last year. On average, research analysts anticipate that Schrodinger will post -2.37 EPS for the current year.

Institutional Investors Weigh In On Schrodinger

Hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. lifted its stake in shares of Schrodinger by 2.0% during the fourth quarter. Vanguard Group Inc. now owns 6,464,426 shares of the company’s stock valued at $115,584,000 after buying an additional 125,349 shares during the period. Rubric Capital Management LP raised its holdings in Schrodinger by 5.4% in the 3rd quarter. Rubric Capital Management LP now owns 5,268,817 shares of the company’s stock valued at $105,692,000 after acquiring an additional 268,817 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its stake in shares of Schrodinger by 3.5% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,714,767 shares of the company’s stock worth $84,300,000 after purchasing an additional 160,198 shares during the period. Amova Asset Management Americas Inc. boosted its holdings in shares of Schrodinger by 1.8% during the third quarter. Amova Asset Management Americas Inc. now owns 2,638,935 shares of the company’s stock worth $52,937,000 after purchasing an additional 47,443 shares during the last quarter. Finally, Nikko Asset Management Americas Inc. boosted its holdings in shares of Schrodinger by 7.2% during the second quarter. Nikko Asset Management Americas Inc. now owns 2,591,492 shares of the company’s stock worth $52,089,000 after purchasing an additional 174,684 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

About Schrodinger

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.